Amgen

Gilead Sciences

Vertex Pharmaceuticals

Regeneron Pharmaceuticals

IQVIA Hlds

Illumina

Natera

Biogen

ICON

Alnylam Pharmaceuticals

VanEck Vectors Biotech ETF

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

Deep Value ETF

iShares Nasdaq Biotechnology ETF

In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading contenders and that could be the starting point of a massive marriage, according to recent reports.

3 Gilead-Heavy ETFs To Watch Amid The AstraZeneca-Gilead Rumor

ARK Genomic Revolution Multi-Sector ETF

First Trust NYSE Arca Biotechnology Index Fund

SPDR S&P Biotech ETF

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Global X Robotics & Artificial Intelligence ETF

ProShares Long Online/Short Stores ETF

Global X Cloud Computing ETF

Amplify Online Retail ETF

iShares Robotics & Artificial Intelligence Multisector ETF

US Global Jets ETF

First Trust Cloud Computing ETF

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

These ETF Areas Make Great Investment Choices in June

From VanEck Global With the COVID-19 pandemic showing few signs of easing, biotech companies are racing to meet soaring demand for treatments, vaccines and testing kits. This is helping to drive renewed investor interest in the biotech sector.

Race for Cure Drives Biotech Stocks

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Biotech ETFs Soaring on COVID-19 Vaccine Progress

There’s no denying biotechnology ETFs are benefiting from the race to cure and treat and the novel coronavirus. Just look at the VanEck Vectors Biotech ETF (BBH), which is higher by more than 7% over just the past month.

Biotech Benefits as Companies Race to Cure Coronavirus

AstraZeneca

Loncar Cancer Immunotherapy ETF

With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea.

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

Positive data on early-stage coronavirus vaccine trial sent Moderna shares surging.

Moderna Soars: Biotech ETFs in Focus

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q1 earnings releases amid the coronavirus crisis.

Are Biotech ETFs in Trouble as Coronavirus Dims Guidance?

Rising investor interest in coronavirus related stocks will benefit these ETFs

Biotech ETFs Poised to Benefit From Coronavirus

Invesco Dynamic Biotechnology & Genome ETF

As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.

Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.

Healthcare ETFs to Gain on Progress in Coronavirus Vaccine

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Investors who were attaching their hopes for a swift end to the coronavirus pandemic to the antiviral medicine remdesivir from Gilead Sciences were disappointed, as Gilead released news Thursday that while the data suggests a “potential benefit,” the drug failed to increase the improvement of patients with COVID-19 or prevent them from dying, according to results [...]

Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead

Yes, many biotech stocks are down at the moment. But that sets up an incredible chance to get some of the best at a discount.

Biotech Stocks: Big Buying Opportunities in 2020’s Sector of the Year

Aytu BioScience

Co-Diagnostics

Forty Seven Inc

Vir Biotechnology

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Coronavirus Scare Supports These Biotech ETFs & Stocks

MicroSectors FANG+ ETN

First Trust Utilities AlphaDEX Fund

VanEck Vectors Gold Miners ETF

Invesco Solar ETF

The fourth-quarter reporting cycle has shown steady improvement with earnings growth on track to turn positive.

Earnings and Coronavirus Impact: 5 Best ETF Charts

First Trust Nasdaq Retail ETF

First Trust Consumer Staples AlphaDEX Fund

iShares Evolved U.S. Innovative Healthcare ETF

Kroger

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

Wanna Be a Value Investor? Follow Buffett & Play 2 ETF Areas

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q4 earnings releases.

Can Biotech ETFs Gain on Mixed Q4 Earnings Results?

This is another election year and one of the presidential variety, meaning investors and voters can expect to hear plenty about politicians’ efforts to lower drug costs.

Biotech ETFs Brush Off Political Attacks on Drug Prices

Companies in the biotech industry face an incredible amount of risk while getting their drugs to market.

The Top Biotech ETFs to Watch in 2020

iShares MSCI Emerging Markets ETF

iShares Global Clean Energy ETF

iShares U.S. Home Construction ETF

Aberdeen Standard Physical Palladium Shares ETF 

Invesco Dynamic Building & Construction ETF

PowerShares Cleantech Portfolio

First Trust NASDAQ Clean Edge Green Energy Index Fund

Schwab Emerging Markets Equity ETF

Vanguard FTSE Emerging Markets ETF

SPDR S&P Homebuilders ETF

As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.

Top ETF Areas for 2020

Biotechnology ETFs, including the VanEck Vectors Biotech ETF (BBH), were laggards for much of 2019, but that scenario rapidly changed at the start of the fourth quarter.

Expect More From Biotech ETFs in 2020

iShares U.S. Healthcare ETF

While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.

Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020

VanEck Vectors Retail ETF

Invesco S&P 500 Enhanced Value ETF

SPDR S&P Aerospace & Defense ETF

Communication Services Select Sector SPDR Fund

Despite the age-old trend of a Santa rally, 2018 was a massive downer. Since 2019 is giving the same cues, investors can seek refuge in these safer ETFs.

News for VanEck Vectors Biotech ETF ETF (BBH)